Author:
Henry Robert R.,Rosenstock Julio,Logan Douglas,Alessi Thomas,Luskey Kenneth,Baron Michelle A.
Funder
Intarcia Therapeutics Inc., Hayward, California
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference28 articles.
1. Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide;Astrup;International Journal of Obesity,2012
2. Economic impact of compliance to treatment with antidiabetes medication in type 2 diabetes mellitus: A review paper;Breitscheidel;Journal of Medical Economics,2010
3. Hypoglycemia, treatment discontinuation, and costs in patients with type 2 diabetes mellitus on oral antidiabetic drugs;Bron;Postgraduate Medicine,2012
4. UCL Study Group for Exenatide. One-year metabolic outcomes in patients with type 2 diabetes treated with exenatide in routine practice;Buysschaert;Diabetes & Metabolism,2010
5. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988–2010;Casagrande;Diabetes Care,2013
Cited by
72 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献